This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Meeting program compliance requirements and pushing back on escalating manufacturer restrictions are the top concerns of pharmacy leaders, as uncovered during the August 2022 Cloudmed 340B Insider interactive webinar. A full 72% of respondents cited one or the other as their primary program concern, with revenue loss largely resulting from discount restrictions ranked third.
Download the full summary report for more information on:
- Additional industry insights
- Regulatory updates from the experts
- Advice on how to offset savings loss
- What to know about compliance and HRSA audits
- FAQs answered by an expert panel